Sputnik V vaccine trials of phase 1 and 2 have been successfully completed in Russia and approved by regulators by the Russian health ministry for public use in Russia. According to the preliminary findings report published in Lancet Journal, non-randomised vaccine trials on 76 people show that two formulations of the vaccine have a good safety profile detected over a span of 42 days...
↧